Literature DB >> 14669337

Impact of endoscopically minimal involvement on IL-8 mRNA expression in esophageal mucosa of patients with non-erosive reflux disease.

Yusei Kanazawa1, Hajime Isomoto, Chun-Yang Wen, Ai-Ping Wang, Vladimir A Saenko, Akira Ohtsuru, Fuminao Takeshima, Katsuhisa Omagari, Yohei Mizuta, Ikuo Murata, Shunichi Yamashita, Shigeru Kohno.   

Abstract

AIM: Little has been known about the pathogenesis of non-erosive reflux disease (NERD). Recent studies have implicated interleukin 8 (IL-8) in the development and progression of gastroesophogeal reflux disease (GERD). The purpose of this study was to determine IL-8 RNA expression levels in NERD patients with or without subtle mucosal changes.
METHODS: We studied 26 patients with NERD and 13 asymptomatic controls. Biopsy sample was taken from the esophagus 3 cm above the gastroesophageal junction and snap frozen for measurement of IL-8 mRNA levels by real-time quantitative polymerase chain reaction (PCR). We also examined mRNA expression of IL-8 receptors, CXCR-1 and -2 by reverse transcriptase PCR. The patients were endoscopically classified into grade M (mucosal color changes without visible mucosal break) and N (neither minimal involvement nor mucosal break) of the modified Los Angeles classification.
RESULTS: The relative IL-8 mRNA expression levels were significantly higher in esophageal mucosa of NERD patients than those in esophageal mucosa of the controls. There was a significant difference in IL-8 mRNA levels between grades M and N. The CXCR-1 and -2 mRNAs were constitutively expressed in esophageal mucosa.
CONCLUSION: Our results suggest that high IL-8 levels in esophageal mucosa may be involved in the pathogenesis of NERD through interaction with its receptors. NERD seems to be composed of a heterogeneous population in terms of not only endoscopically minimal involvement but also immune and inflammatory processes.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14669337      PMCID: PMC4612056          DOI: 10.3748/wjg.v9.i12.2801

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  22 in total

1.  Large deletions in mitochondrial DNA in radiation-associated human thyroid tumors.

Authors:  Tatiana I Rogounovitch; Vladimir A Saenko; Yuki Shimizu-Yoshida; Aleksandr Yu Abrosimov; Eugeny F Lushnikov; Pavel O Roumiantsev; Akira Ohtsuru; Hiroyuki Namba; Anatoly F Tsyb; Shunichi Yamashita
Journal:  Cancer Res       Date:  2002-12-01       Impact factor: 12.701

2.  The endoscopic assessment of esophagitis: a progress report on observer agreement.

Authors:  D Armstrong; J R Bennett; A L Blum; J Dent; F T De Dombal; J P Galmiche; L Lundell; M Margulies; J E Richter; S J Spechler; G N Tytgat; L Wallin
Journal:  Gastroenterology       Date:  1996-07       Impact factor: 22.682

3.  Diversity in the oesophageal phenotypic response to gastro-oesophageal reflux: immunological determinants.

Authors:  R C Fitzgerald; B A Onwuegbusi; M Bajaj-Elliott; I T Saeed; W R Burnham; M J G Farthing
Journal:  Gut       Date:  2002-04       Impact factor: 23.059

4.  Overexpression of CXC-chemokines and CXC-chemokine receptor type II constitute an autocrine growth mechanism in the epidermoid carcinoma cells KB and A431.

Authors:  B Metzner; C Hofmann; C Heinemann; U Zimpfer; I Schraufstätter; E Schöpf; J Norgauer
Journal:  Oncol Rep       Date:  1999 Nov-Dec       Impact factor: 3.906

5.  Helicobacter pylori infection in patients with gastric involvement by adult T-cell leukemia/lymphoma.

Authors:  Ken Ohnita; Hajime Isomoto; Yohei Mizuta; Takahiro Maeda; Masuho Haraguchi; Masanobu Miyazaki; Kunihiko Murase; Ikuo Murata; Masao Tomonaga; Shigeru Kohno
Journal:  Cancer       Date:  2002-03-01       Impact factor: 6.860

6.  Interleukin-8 messenger ribonucleic acid expression correlates with tumor progression, tumor angiogenesis, patient survival, and timing of relapse in non-small-cell lung cancer.

Authors:  A Yuan; P C Yang; C J Yu; W J Chen; F Y Lin; S H Kuo; K T Luh
Journal:  Am J Respir Crit Care Med       Date:  2000-11       Impact factor: 21.405

7.  5-day vs. 7-day triple therapy with rabeprazole, clarithromycin and amoxicillin for Helicobacter pylori eradication.

Authors:  H Isomoto; H Furusu; T Morikawa; Y Mizuta; T Nishiyama; K Omagari; K Murase; K Inoue; I Murata; S Kohno
Journal:  Aliment Pharmacol Ther       Date:  2000-12       Impact factor: 8.171

8.  Inflammatory gradient in Barrett's oesophagus: implications for disease complications.

Authors:  R C Fitzgerald; S Abdalla; B A Onwuegbusi; P Sirieix; I T Saeed; W R Burnham; M J G Farthing
Journal:  Gut       Date:  2002-09       Impact factor: 23.059

9.  The usefulness of a structured questionnaire in the assessment of symptomatic gastroesophageal reflux disease.

Authors:  R Carlsson; J Dent; E Bolling-Sternevald; F Johnsson; O Junghard; K Lauritsen; S Riley; L Lundell
Journal:  Scand J Gastroenterol       Date:  1998-10       Impact factor: 2.423

10.  Regulation of the expression of IL-8 receptor A/B by IL-8: possible functions of each receptor.

Authors:  A Chuntharapai; K J Kim
Journal:  J Immunol       Date:  1995-09-01       Impact factor: 5.422

View more
  10 in total

Review 1.  Inflammatory mediators in gastroesophageal reflux disease: impact on esophageal motility, fibrosis, and carcinogenesis.

Authors:  Florian Rieder; Piero Biancani; Karen Harnett; Lisa Yerian; Gary W Falk
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2010-03-18       Impact factor: 4.052

Review 2.  Changes in the esophageal mucosa of patients with non erosive reflux disease: How far have we gone?

Authors:  Christos Triantos; Nikolaos Koukias; Georgios Karamanolis; Konstantinos Thomopoulos
Journal:  World J Gastroenterol       Date:  2015-05-21       Impact factor: 5.742

3.  Prevention by rebamipide of acute reflux esophagitis in rats.

Authors:  Kazuhiro Katada; Norimasa Yoshida; Yutaka Isozaki; Naoya Tomatsuri; Hiroshi Ichikawa; Yuji Naito; Takeshi Okanoue; Toshikazu Yoshikawa
Journal:  Dig Dis Sci       Date:  2005-10       Impact factor: 3.199

4.  Expression of CXC receptor 1 and 2 in esophageal mucosa of patients with reflux esophagitis.

Authors:  Hajime Isomoto; Yusei Kanazawa; Yoshito Nishi; Chun-Yang Wen; Kenichiro Inoue; Shigeru Kohno
Journal:  World J Gastroenterol       Date:  2005-03-28       Impact factor: 5.742

5.  Impedance-pH reflux patterns can differentiate non-erosive reflux disease from functional heartburn patients.

Authors:  Edoardo Savarino; Patrizia Zentilin; Radu Tutuian; Daniel Pohl; Lorenzo Gemignani; Alberto Malesci; Vincenzo Savarino
Journal:  J Gastroenterol       Date:  2011-10-25       Impact factor: 7.527

6.  Targeting chemokine pathways in esophageal adenocarcinoma.

Authors:  Makardhwaj S Shrivastava; Zulfiqar Hussain; Orsolya Giricz; Niraj Shenoy; Rahul Polineni; Anirban Maitra; Amit Verma
Journal:  Cell Cycle       Date:  2014       Impact factor: 4.534

7.  Reactive oxygen species and chemokines: are they elevated in the esophageal mucosa of children with gastroesophageal reflux disease?

Authors:  Engin Tutar; Deniz Ertem; Goksenin Unluguzel; Sevda Tanrikulu; Goncagul Haklar; Cigdem Celikel; Evin Ademoglu; Ender Pehlivanoglu
Journal:  World J Gastroenterol       Date:  2008-05-28       Impact factor: 5.742

8.  Gastroesophageal reflux activates the NF-κB pathway and impairs esophageal barrier function in mice.

Authors:  Yu Fang; Hao Chen; Yuhui Hu; Zorka Djukic; Whitney Tevebaugh; Nicholas J Shaheen; Roy C Orlando; Jianguo Hu; Xiaoxin Chen
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2013-05-02       Impact factor: 4.052

9.  Immune and Inflammatory Responses in GERD and Lansoprazole.

Authors:  Hajime Isomoto; Yoshito Nishi; Yusei Kanazawa; Saburo Shikuwa; Yohei Mizuta; Kenichiro Inoue; Shigeru Kohno
Journal:  J Clin Biochem Nutr       Date:  2007-09       Impact factor: 3.114

10.  Esophageal Baseline Impedance Reflects Mucosal Integrity and Predicts Symptomatic Outcome With Proton Pump Inhibitor Treatment.

Authors:  Chenxi Xie; Daniel Sifrim; Yuwen Li; Minhu Chen; Yinglian Xiao
Journal:  J Neurogastroenterol Motil       Date:  2018-01-30       Impact factor: 4.924

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.